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Abstract: The anaesthetic and cardiopulmonary effects of medetomidine-ketamine (MK) and xylazine-ketamine (XK) combinations
were compared in rabbits. A total of 18 rabbits were randomly assigned to 2 different groups. The rabbits in the MK group (n =
9) were given 0.25 mg/kg of medetomidine and 50 mg/kg of ketamine intramuscularly. The XK group was given 4 mg/kg of xylazine
and 50 mg/kg of ketamine via the same route. Data on reflexes (righting, ear pinch and pedal withdrawal) and cardiopulmonary
parameters (heart rate, respiratory rate, mean blood pressure, and blood gas values) were recorded before and 5, 10, 15, 30, 45,
60, 75, 90 and 120 min after anaesthesia. Total sleep time, mean duration of loss of ear pinch reflex and mean duration of pedal
withdrawal reflex were significantly longer in the MK group than in the XK group (P < 0.05). Duration of surgical anaesthesia was
significantly longer in the MK group than in the XK group (P < 0.05). Both combinations caused moderate bradycardia, moderate
or marked hypoxaemia, moderate hypercapnia and moderate acidosis. It was concluded that the MK combination provided suitable
anaesthesia for rabbits, characterised by rapid induction and recovery as the arterial oxygen tension is reduced to hypoxaemic levels
during the use of this combination, and the supplemental administration of oxygen is recommended.
Key Words: Medetomidine, xylazine, ketamine, anaesthesia, rabbit.

Tavflanlarda Medetomidin-Ketamin ve Xylazin-Ketamin Anestezisinin Karfl›laflt›r›lmas›
Özet: Bu çal›flmada, tavflanlarda medetomidin-ketamin kombinasyonu ile ksilazin-ketamin kombinasyonunun anestezik ve
kardiyopulmoner etkileri karfl›laflt›r›lm›flt›r. Toplam 18 tavflan iki farkl› gruba ayr›ld›. Grup MK’ye (n = 9) 0,25 mg/kg medetomidin
ve 50 mg/kg ketamin kas içi yolla uyguland›. Grup XK (n = 9)’deki hayvanlara ayn› yolla 4 mg/kg xylazine ve 50 mg/kg ketamine
uyguland›. Anestezi öncesi ve anesteziden 5, 10, 15, 30, 45, 60, 75, 90 ve 120 dakika sonra refleksler (ayakta kalma, kulak ve
arka pedal) ve kardiyopulmoner parametreler (kalp frekans›, solunum frekans›, ortalama kan bas›nc›, kan gazlar› seviyesi) her iki
grupta incelendi. Anestezi süresi, arka pedal ve kulak reflekslerinin kaybolma süresi MK grubunda XK grubuna nazaran önemli
derecede uzundu (P < 0,05). Ayr›ca cerrahi anestezi süresinin MK grubunda XK grubuna nazaran istatistiksel olarak anlaml› derecede
uzun oldu¤u tespit edilmifltir (P < 0,05). Her iki grupta da hafif dereceli bir bradikardi, hafif veya orta dereceli bir hipoksemi, hafif
dereceli hiperkapni ve asidozis tespit edilmifltir. Sonuç olarak, anesteziye girifl ve anesteziden h›zl› bir ç›k›fl sa¤lad›¤› için tavflanlarda
medetomidin-ketamin kombinasyonunun kullan›lmas› uygun bulunmufltur. Ayr›ca medetomidin-ketamin hipoksiye neden oldu¤undan
oksijenasyonun mutlaka sa¤lanmas› gerekti¤i anlafl›lm›flt›r.
Anahtar Sözcükler: Medetomidin, ksilazin, ketamin, anestezi, tavflan.

Introduction
The rabbit is widely used as a laboratory animal for
experimental surgery. It has also gained increasing
popularity among urban families as a domestic pet. A safe
anaesthetic method is therefore needed both for
surgeons untertaking research and for practising
veterinarians. Especially in veterinary practice anaesthesia
of the rabbit may present problems unless the method is
easy to apply and efficient and safe to use. Intubation of
the rabbit and use of a volatile anaesthetic agent, possibly
in combination with muscle relaxants, may be too

complicated and time-consuming for the practitioner and
sometimes even for scientists or surgeons who often
perform experimental surgical research alone without any
sophisticated devices (1).
Among the many methods of anaesthetising the rabbit
described in the literature a combination of several
injectable drugs (fentanyl/fluanisone, ketamine/
acepromazine, and ketamine/diazepam) seems to be the
most popular (2,3). Fentanyl, fluanisone and diazepam
combinations have been used in 565 rabbits for
experimental orthopaedic surgery (4). Although this
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combination is safe in comparison with other techniques,
it produces a relatively long recovery period (2,4).
When ketamine is used as a sole anaesthetic agent it
tends to cause hypertonus, poor muscle relaxation,
persistent pain reflex responses and violent recovery
from anaesthesia (5). To counteract these undesirable
side effects various drugs such as xylazine, an α2-agonist
compound, have been used in combination with ketamine.
Ketamine combined with xylazine has been reported to
produce good anaesthesia in the rabbit, but with some
mortality (6).
Medetomidine is a potent α2-adrenoceptor agonist
that induces sedation, analgesia and muscle relaxation
(7). Its mechanism of action is similar to that of xylazine
and it has been successfully combined with ketamine for
anaesthesia in a range of species (8-17). In rabbits,
medetomidine has been reported to produce sedation and
some analgesia at doses of 0.25, 0.35 and 0.50 mg/kg
IM (13). Dose rates of 0.25 mg/kg and 0.50 mg/kg
produced a moderate depression in heart rate, blood
pressure and arterial PO2 (13). When combined with
ketamine, moderate surgical anaesthesia is produced,
although a wide range of dose rates have been reported
as being effective. In an initial evaluation, ketamine and
medetomidine at 25 mg/kg + 0.5 mg/kg and 60 mg/kg +
0.5 mg/kg IM doses produced surgical anaesthesia in
some but not all animals (7). Ketamine (20 mg/kg),
medetomidine (0.3 mg/kg) and diazepam (0.75-1.5
mg/kg) administered subcutaneously to rabbits
undergoing orthopaedic surgery resulted in a surgical
plane of anaesthesia, but with serious hypoxia and
moderate hypercapnia (14).
Although a range of different injectable agents can be
used in the rabbit, ketamine/medetomidine offers the
advantage of relatively rapid recovery, since the effect of
medetomidine can be reversed using the specific
antagonist, atipemazole (1-3,17).
The aim of this study was to evaluate the anaesthetic
and cardiopulmonary effects of the MK combination and
to compare it with the XK combination in rabbits.

Materials and Methods
Animals
The study was performed in 18 young female adult
chinchilla rabbits with a mean body weight of 3.0 ± 0.5
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kg. The rabbits were kept in a controlled environment
(room temperature, 18-21 °C; humidity, 55-65%), fed a
commercial pellet diet (Kaninchen Haltung 2020,
Altromin) and allowed ad libitum access to water. A
standard clinical examination preceeded general
anaesthesia.
Anaesthetic protocol
The rabbits were randomly assigned to 2 different
groups. The rabbits in group MK (n = 9) were given 0.25
mg/kg of medetomidine (Domitor, Smith Kline Beacham,
1 mg/ml) and 50 mg/kg of ketamine (Narketan 10,
Chassot, 100 mg/ml) intramuscularly (IM). Group XK was
given 4 mg/kg of xylazine (Xylapan, Chassot, 20 mg/ml)
and 50 mg/kg of ketamine via the same route. All drugs
were mixed in a single syringe for injection.
Local anaesthetic cream (Xylocain 2%, Astra) was
applied to the rabbits’ ears 45 min before induction of
anaesthesia to prevent pain during catheter insertion.
Prior to induction of anaesthesia a catheter (Venflon 22
SWG, Ohmeda, Helsingborg, Sweden) was placed in the
ear artery and connected to a pressure transducer
(Statham, USA) to monitor arterial blood pressure.
After placement of the catheters, baseline recordings
of respiratory rate, mean arterial blood pressure (MAP)
and heart rate were obtained for a 2 min period. An
arterial blood sample (0.5-1 ml) was then obtained for
blood gas analysis and the anaesthetic combination was
administered. Depth of anaesthesia was assessed by
recording the presence or absence of a righting response
(the animal showing the ability to spontaneously right
itself after being placed on its back), an ear pinch
response (shaking the head or vocalisation when the
pinna was pinched using the investigator’s fingernails)
and pedal withdrawal response (PWR) (withdrawal of the
hind limb in response to pinching 1 digit with the
investigator’s fingernails). Simple eye ointment
(Bepanthene, Roche) was administered in both eyes to
prevent drying of the corneal surface. Recordings of
heart rate and MAP were made for a 2 min period prior
to withdrawal of additional blood samples at 5, 10, 15,
30, 45, 60, 75, 90 and 120 min during anaesthesia for
blood gas analysis (using an IL Blood Gas Analyzer,
Instrumentation Laboratory, USA). Monitoring was
continued until the animal regained its righting reflex. At
the end of the study, the rabbits were re-homed.
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Statistical evaluation and data processing
Statistical analyses were performed using SPSS
software. Data were recorded as mean ± SD. Student’s ttest was applied to unpaired data for comparisons within
the group.The MK combination was compared with the
xylazine-ketamin combination using the paired Student’s
t-test. Values of P < 0.05 were considered statistically
significant.

Results
Depth of anaesthesia
Both groups lost the righting reflex and ear pinch
response. The righting reflex was lost within 5 min in all
rabbits. The time of loss of the righting reflex did not
differ significantly between the groups (Table 1). Total
sleep time was significantly longer in MK (150 ± 30 min)
than in XK (120 ± 25 min, P < 0.05). The duration of
loss of the ear pinch reflex was significantly greater in MK
(55 ± 19 min) than in XK (30 ± 15 min, P < 0.05). A
similarly longer PWR loss occurred with MK (50 ± 28
min) compared with XK (28 ± 19 min, P < 0.05).
Duration of surgical anaesthesia was significantly longer
for the MK group (45 ± 26 min) than for the XK group
(20 ± 11 min, P < 0.05) (Table 1).
Cardiorespiratory effects
Pre-induction heart rate (HR) varied between 200.3
± 20.5 and 203.3 ± 15.6 beats per minute for MK and
XK, respectively. HR was significantly below the baseline
value during anaesthesia in both groups. Both
combinations caused moderate bradycardia, the lowest

rates being 143.2 ± 23.5 and 153.4 ± 22.8 for MK and
XK, respectively. HR was significantly higher in rabbits
given XK than in those given MK at 5, 10, 15, 30 and 45
min (P < 0.05) (Table 2). The resting respiratory rate
(RR) of chinchilla rabbits, observed undisturbed, has been
recorded as 59 ± 9 breaths per minute. All rabbits were
tachypnoeic before induction, varying between 187.3 ±
25.5 and 182.3 ± 30.8 breaths per minute. The lowest
respiratory rates during anaesthesia were 30.2 ± 7.5 and
30.8 ± 7.5 breaths per minute (between 15 and 60 min
after induction) for MK and XK, respectively. The RR in
the XK group was significantly higher compared with the
MK group between 45 and 75 min after application (P <
0,05). Mean arterial blood pressure (MAP) before
induction varied between 82.0 ± 10.1 mm Hg for MK
and 83.2 ± 8.2 mm Hg for XK. The effects of MK
administration in rabbits were minimal, the lowest MAP
values over the first 90 min being recorded as 69.9 ± 9.7
mm Hg. The XK combination caused moderate
hypotension, the lowest MAP values being 59.3 mm Hg
(Table 2). The MAP in group MK was significantly higher
compared with that in group XK between 5 and 90 min
after application (P < 0.05).
Effect on blood gas values
All blood gas values are shown in Table 3. Before
induction of anaesthesia, arterial PaO2 and PaCO2 varied
between 83.3 ± 3.5 and 80.1 ± 6.5 and 28.7 ± 2.1 and
29.7 ± 2.6 mm Hg for MK and XK, respectively. Arterial
pH varied between 7.48 ± 0.02 for MK and 7.48 ± 0.03
for XK, respectively. Both combinations produced
moderate hypoxaemia between 5 and 90 min after
application. All rabbits were visibly cyanotic shortly after

Table 1. The mean times (± SD) to loss of the righting reflex, sleep time, duration of loss of ear pinch and duration of loss of pedal withdrawal
response in 18 chinchilla rabbits after the intramuscular injection of a combination of medetomidine-ketamine or a combination of xylazineketamine.
Anaesthetic combination

MK

XK

Time to loss of righting reflex (minutes)

1.8 ± 0.4

2.0 ± 0.4

Sleep time (minutes)

150 ± 30

120 ± 25*

Duration of loss of ear pinch (minutes)

55 ± 19

30 ± 15*

Duration of loss of pedal withdrawal response (minutes)

50 ± 28

28 ± 19*

Surgical anaesthesia (minutes)

45± 26

20± 11*

MK= Medetomidine 0.25 mg/kg + ketamine 50 mg/kg
XK = Xylazine 4 mg/kg + ketamine 50 mg/kg
*Mean value differs significantly (P < 0.05) from MK
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Table 2. Effects of IM administration of medetomidine (0.25 mg/kg)-ketamine (50 mg/kg) and xylazine (4 mg/kg)-ketamine (50 mg/kg) on
cardiorespiratory values in chinchilla rabbits.

Time

HR (beats/min)

RR (breaths/min)

MAP (mm of Hg) (min)

(min)

MK

XK

MK

XK

MK

XK

0
5
10
15
30
45
60
75

200.3 ± 20.5
160.2 ± 22.0†
158.3 ± 21.8†
155.7 ± 20.7†
145.6 ± 20.3†
143.2 ± 23.5†
148.7 ± 23.8†
150.3 ± 3.5†

203.3 ± 15.6
191 ± 25.1†*
180.3 ± 25.5†*
170.6 ± 24.5†*
153.4 ± 22.8†*
154.0 ± 25.9†*
158.3 ± 21.0†
158.6 ± 19.2†

187.3 ± 25.5
56.3 ± 17.5†
50.8 ± 13.2†
48.3 ± 11.5†
30.3 ± 12.7†
30.2 ± 7.5†
35.3 ± 7.9†
40.3 ± 14.5†

182.3 ± 30.8
50.3 ± 16.2†
44.2 ± 8.5†
42.5 ± 7.5†
30.8 ± 10.5†
38.3 ± 13.5†*
47.8 ± 15.5†*
59.3 ± 17.4†*

82 ± 10.1
89.3 ± 10.2
88.5 ± 9.8
88.9 ± 10.5
89.4 ± 10.5
86.2 ± 11.4
80.1 ± 12.1
78.3 ± 12.8†

83.2 ± 8.2
68.8 ± 13.0†*
73.3 ± 10.6†*
74.1 ± 10.5†*
73.7 ± 12.1†*
70.2 ± 12.1†*
65.4 ± 11.2†*
65.1 ± 10.3†*

90
120

155.2 ± 22.3†
152.3 ± 22.5†

160.2 ± 19.1†
158.3 ± 20.9†

52.7 ± 22.5†
59.9 ± 29.8†

58.3 ± 20.7†
58.1 ± 30.5†

69.6 ± 9.7†
62.3 ± 10.5†

59.3 ± 8.5†*
61.7 ± 10.5†

Values reported are mean ± SEM (range). *Mean value differs significantly (P < 0.05) from MK. † Mean value differs significantly (P < 0.05) from
baseline value. MK = medetomidine 0.25 mg/kg + ketamine 50 mg/kg. XK = xylazine 4 mg/kg + ketamine 50 mg/kg. HR = heart rate; RR = respiratory rate; MAP = mean arterial blood pressure

Table 3. Effects of IM administration of medetomidine (0.25 mg/kg)-ketamine (50 mg/kg) and xylazine (4 mg/kg)- ketamine (50 mg/kg) on blood
gas values in chinchilla rabbits.

Time

Arterial pH

PaO2

PaCO2

(min)

MK

XK

MK

XK

MK

XK

0
5
10
15
30
45
60
75
90
120

7.48 ± 0.02
7.38 ± 0.04†
7.36 ± 0.04†
7.29 ± 0.03†
7.31 ± 0.03†
7.34 ± 0.04†
7.37 ± 0.04†
7.39 ± 0.03†
7.40 ± 0.03†
7.40 ± 0.02†

7.48 ± 0.03
7.41 ± 0.03†*
7.41 ± 0.04†*
7.36 ± 0.04†*
7.43 ± 0.06†*
7.44 ± 0.04†*
7.45 ± 0.05*
7.44 ± 0.03†*
7.44 ± 0.04†*
7.44 ± 0.03†

83.3 ± 3.5
40.1 ± 3.1†
41.3 ± 3.0†
42.1 ± 4.5†
44.3 ± 6.2†
52.7 ± 8.5†
55.6 ± 10.7†
67.4 ± 12.5
67.4 ± 8.6
74.5 ± 8.5

80.1 ± 6.5
47.9 ± 5.8†*
50.4 ± 5.5†*
44.8 ± 5.8†
46.3 ± 7.9†
55.7 ± 9.5†
61.8 ± 11.7
77.8 ± 8.6
77.9 ± 9.2
79.1 ± 6.4

28.7 ± 2.1
36.8 ± 5.7†
39.5 ± 4.4†
37.7 ± 2.2†
38.4 ± 3.1†
46.2 ± 5.6†
45.7 ± 6.1†
43.8 ± 7.1†
42.7 ± 6.4†
39.4 ± 4.8†

29.7 ± 2.6
35.6 ± 2.8†
35.8 ± 3.4†*
34.7 ± 5.1†*
35.1 ± 6.0†*
34.7 ± 7.6†*
35.7 ± 8.1†*
35.3 ± 4.2†*
35.2 ± 4.1†*
33.8 ± 3.8*

Values reported are mean ± SEM (range). *Mean value differs significantly (P < 0.05) from MK. † Mean value differs significantly (P < 0.05) from
baseline value.
MK = medetomidine 0.25 mg/kg + ketamine 50 mg/kg
XK = xylazine 4 mg/kg + ketamine 50 mg/kg

induction. Hypoxaemia was reversed within 15 min in all
cases. Both groups produced moderate hypercapnia, the
highest means varying between 46.2 ± 5.6 for MK and
35.8 ± 3.4 mm Hg for XK (at 5-60 min of anaesthesia).
The lowest arterial pHs varied between 7.29 ± 0.03 and
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7.36 ± 0.04 for MK and XK, respectively and were
reached between 5 and 45 min of anaesthesia. The pH
value in the XK group was significantly higher compared
with that of the MK group between 5 and 90 min after
application (P < 0.05).
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Discussion
Medetomidine formed a suitable combination with
ketamine for anaesthesia of chinchilla rabbits. It greatly
potentiated the anaesthetic effect of ketamine, since 50
mg/kg of ketamine combined with 0.25 mg/kg of
medetomidine produced a more prolonged anaesthesia
than 50 mg/kg of ketamine combined with 4 mg/kg of
xylazine. For the purposes of comparison the
medetomidine-ketamine combination can be considered
as approximately equivalent to the xylazine-ketamine
combination, which is in agreement with the findings in
dogs and cats (12,16). Ketamine and medetomidine have
been tested in New Zealand white rabbits in 4 different
combinations (18). It was suggested that 15 mg/kg of
ketamine and 0.25 mg/kg of medetomidine was
appropriate for most common surgical procedures (e.g.,
ovariohysterectomy and castration). It is possible that
strain variation in response may necessitate the
administration of a higher or lower dose. For example,
the pigmented outbred rabbits anaesthetised by
Nevalainen et al. (7) were not all surgically anaesthetised,
even at the higher dose rates of ketamine used (60-75
mg/kg). Rabbits that received this increased dose of
ketamine (60 mg/kg) combined with 0.5 mg/kg of
medetomidine showed fewer anaesthetic effects, while in
the present study increasing the dose of ketamine alone
increased the duration of surgical anaesthesia. When
evaluating anaesthetic depth, it was noted that when the
pedal withdrawal reflex was absent a positive response
was sometimes observed when the stimulus was repeated
(1,2). The first stimulus seemed to arouse the animal to
a state in which a repeated stimulus evoked a response.
Since most surgical procedures include repetitive
nociceptive stimulation, it seems logical to evaluate
reflexes by repeating the stimulus when evaluating
anaesthetic depth.
In these studies, the positive chronotropic effect of
ketamine temporarily counterbalanced the bradycardiac
effect of the α2-agonist medetomidine in a dose
dependent manner, as has already been reported in dogs
and cats (12,16). The significantly higher heart rates in

the rabbits anaesthetised with XK compared with the
rabbits anaesthetised with MK could have been due to the
shorter bradycardiac effect of xylazine.
Xylazine-ketamine and medetomidine-ketamine
combinations depressed respiratory rates in the same
way. Nevertheless, in this and other previously published
studies of ketamine and medetomidine in rabbits,
moderate to marked hypoxia, moderate hypercapnia and
moderate acidosis have been noted (14,18,19) and it is
recommended that oxygen supplementation be provided
when these agents are used for anaesthesia. It should be
noted that this depression of respiratory function is not
unique to the use of ketamine-medetomidine, but also
occurs with other injectable anaesthetic regimens in this
species (19,20).
Previous studies (5,6) have indicated that the
administration of xylazine in rabbits produces a decrease
in blood pressure. Medetomidine exhibits similar effects
(7,10,12). Therefore, in combination, the centrally
stimulating effects of ketamine balance the depressive
effects of α2-agonist compounds, as was evident with the
medetomidine-ketamine combination tested in this study.
Indeed, increasing the dose of ketamine cancelled the
hypotension related to medetomidine administration.
An obvious advantage with the technique described is
that the effects of medetomidine can be reversed rapidly
and completely by the administration of atipemazole
(1,7,17). With reversal of anaesthesia, the sleep time is
reduced, and the animal returns to a normal physiological
state much faster. Since atipemazole reversed all of the
analgesic effects of medetomidine, additional analgesia
should be provided, for example by administration of an
NSAID such as carprofen before reversal of anaesthesia
(21).
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